Cochrane Abstracts
Immunity after COVID‐19 vaccination in people with higher risk of compromised immune status: a scoping review
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Immunity After COVID‐19 Vaccination in People With Higher Risk of Compromised Immune Status: a Scoping Review." Cochrane Abstracts, John Wiley & Sons, Inc, 2026. Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/435744/all/Immunity_after_COVID‐19_vaccination_in_people_with_higher_risk_of_compromised_immune_status:_a_scoping_review.
Immunity after COVID‐19 vaccination in people with higher risk of compromised immune status: a scoping review. Cochrane Abstracts. John Wiley & Sons, Inc; 2026. https://evidence.unboundmedicine.com/evidence/view/Cochrane/435744/all/Immunity_after_COVID‐19_vaccination_in_people_with_higher_risk_of_compromised_immune_status:_a_scoping_review. Accessed February 7, 2026.
Immunity after COVID‐19 vaccination in people with higher risk of compromised immune status: a scoping review. (2026). In Cochrane Abstracts. John Wiley & Sons, Inc. https://evidence.unboundmedicine.com/evidence/view/Cochrane/435744/all/Immunity_after_COVID‐19_vaccination_in_people_with_higher_risk_of_compromised_immune_status:_a_scoping_review
Immunity After COVID‐19 Vaccination in People With Higher Risk of Compromised Immune Status: a Scoping Review [Internet]. In: Cochrane Abstracts. John Wiley & Sons, Inc; 2026. [cited 2026 February 07]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/435744/all/Immunity_after_COVID‐19_vaccination_in_people_with_higher_risk_of_compromised_immune_status:_a_scoping_review.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Immunity after COVID‐19 vaccination in people with higher risk of compromised immune status: a scoping review
ID - 435744
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/435744/all/Immunity_after_COVID‐19_vaccination_in_people_with_higher_risk_of_compromised_immune_status:_a_scoping_review
PB - John Wiley & Sons, Inc
DB - Evidence Central
DP - Unbound Medicine
ER -
